子宫平滑肌肿瘤中Raf激酶抑制蛋白的表达:平滑肌肉瘤的诊断标志物?
研究分析Raf激酶抑制蛋白(RKIP)在各类子宫平滑肌瘤亚型及平滑肌肉瘤中的免疫组化表达,并在SK-LMS-1细胞系中敲低或过表达RKIP以观察细胞活力、迁移和克隆形成能力。结果示奇异核平滑肌瘤表达高于普通型,富细胞型和平滑肌肉瘤表达降低或缺失;RKIP敲除使克隆形成能力显著增加(P=0.011)。作者认为RKIP在子宫平滑肌疾病中值得进一步研究。
要点
- RKIP免疫组化在奇异核平滑肌瘤中高于普通型平滑肌瘤
- RKIP在富细胞型平滑肌瘤中表达降低,在平滑肌肉瘤中通常缺失
- SK-LMS-1细胞中RKIP敲除使克隆形成能力显著增加(P=0.011)
核心结论
- RKIP在平滑肌瘤各组织型与平滑肌肉瘤中表达模式不同,且影响平滑肌肉瘤细胞的克隆形成,作者认为这鼓励在子宫平滑肌疾病中进一步研究RKIP。
研究设计与样本
- 对平滑肌瘤与平滑肌肉瘤标本行免疫组化染色。
- 对平滑肌肉瘤SK-LMS-1细胞系进行RKIP敲低和过表达,并行细胞活力、伤口愈合迁移和克隆形成实验。
主要发现
- RKIP免疫组化表达在奇异核平滑肌瘤中高于普通型平滑肌瘤。
- RKIP表达在富细胞型平滑肌瘤中降低,在平滑肌肉瘤中通常染色缺失。
- 在SK-LMS-1细胞系中操控RKIP表达后,细胞活力和迁移能力随时间未见明显差异。
- RKIP敲除导致细胞形成克隆的能力显著增加(P = 0.011)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: What is the expression pattern of Raf kinase inhibitory protein (RKIP) in different subtypes of leiomyoma (usual type, cellular, apoplectic or haemorrhagic leiomyoma, leiomyoma with bizarre nuclei and lipoleiomyoma) and leiomyosarcoma specimens, and what is its biological role in leiomyosarcoma cells? DESIGN: Leiomyoma and leiomyosarcoma specimens underwent immunohistochemistry staining. Leiomyosarcoma SK-LMS-1 cell line was RKIP knocked down and RKIP overexpressed, and cell viability, wound healing migration and clonogenicity assays were carried out. RESULTS: A higher immunohistochemical expression of RKIP was observed in bizarre leiomyomas, than in usual-type leiomyomas. Decreased expression was also found in cellular leiomyoma, with generally absent staining in leiomyosarcomas. Upon RKIP expression manipulation in SK-LMS-1 cell line, no major differences were observed in cell viability and migration capacity over time. RKIP knockout, however, resulted in a significant increase in the cell's ability to form colonies (P = 0.011). CONCLUSION: RKIP distinct expression pattern among leiomyoma histotype and leiomyosarcoma, and its effect on leiomyosarcoma cells on colony formation, encourages further studies of RKIP in uterine smooth muscle disorders.
引用
- Greco S, Pinheiro J, Cardoso-Carneiro D, et al. Raf kinase inhibitor protein expression in smooth muscle tumours of the uterus: a diagnostic marker for leiomyosarcoma? Reprod Biomed Online. 2024. PMID: 38608337. doi:10.1016/j.rbmo.2024.103816
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。